These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38822164)
21. Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case - control analysis. Miron G; Gurevich M; Baum S; Achiron A; Barzilai A J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2055-2061. PubMed ID: 28609573 [TBL] [Abstract][Full Text] [Related]
22. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis. Cai Q; Teeple A; Wu B; Muser E J Med Econ; 2019 Dec; 22(12):1290-1297. PubMed ID: 31262226 [No Abstract] [Full Text] [Related]
23. Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis). Orsini D; Megna M; Assorgi C; Balato A; Balestri R; Bernardini N; Bettacchi A; Bianchelli T; Bianchi L; Buggiani G; Burlando M; Brunasso A; Caldarola G; Cameli N; Campanati A; Campione E; Carugno A; Chersi K; Conti A; Costanzo A; Cozzani E; Cuccia A; D'Amico D; Dal Bello G; Dall'Olio EG; Dapavo P; De Simone C; Di Brizzi EV; Di Cesare A; Dini V; Esposito M; Errichetti E; Fargnoli MC; Fiorella CS; Foti A; Fratton Z; Gaiani FM; Gisondi P; Giuffrida R; Giunta A; Guarneri C; Legori A; Loconsole F; Malagoli P; Narcisi A; Paolinelli M; Potestio L; Prignano F; Rech G; Rossi A; Skroza N; Trovato F; Venturini M; Richetta AG; Pellacani G; Dattola A J Dermatolog Treat; 2024 Dec; 35(1):2393376. PubMed ID: 39164008 [No Abstract] [Full Text] [Related]
25. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies. Ozakbas S; Ormeci B; Idiman E J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584 [TBL] [Abstract][Full Text] [Related]
26. The Prevalence of Comorbidities Associated with Multiple Sclerosis in Saudi Arabia. Alnajashi H; Wali A; Aqeeli A; Magboul A; Alfulayt M; Baasher A; Alzahrani S Ann Afr Med; 2024 Oct; 23(4):600-605. PubMed ID: 39138964 [TBL] [Abstract][Full Text] [Related]
27. Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials. Lebwohl M; Warren RB; Sofen H; Imafuku S; Paul C; Szepietowski JC; Spelman L; Passeron T; Vritzali E; Napoli A; Kisa RM; Buck A; Banerjee S; Thaçi D; Blauvelt A Br J Dermatol; 2024 Apr; 190(5):668-679. PubMed ID: 38226713 [TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis. Feldman SR; Srivastava B; Abell J; Hoops T; Fakharzadeh S; Chakravarty S; Muser E; Dungee D; Quinn S; Leone-Perkins M; Kappelman M J Drugs Dermatol; 2018 Dec; 17(12):1298-1308. PubMed ID: 30586262 [TBL] [Abstract][Full Text] [Related]
29. Routine Assessment of Patient Index Data 3 Score and Psoriasis Quality of Life Assess Complementary Yet Different Aspects of Patient-Reported Outcomes in Psoriasis and Psoriatic Arthritis. Vakil-Gilani KM; Dinno A; Rich-Garg N; Deodhar A J Clin Rheumatol; 2018 Sep; 24(6):319-323. PubMed ID: 29319548 [TBL] [Abstract][Full Text] [Related]
30. Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis. Truong B; Rich-Garg N; Ehst BD; Deodhar AA; Ku JH; Vakil-Gilani K; Danve A; Blauvelt A Clin Cosmet Investig Dermatol; 2015; 8():563-9. PubMed ID: 26622188 [TBL] [Abstract][Full Text] [Related]
31. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M; Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084 [TBL] [Abstract][Full Text] [Related]
32. Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study. Egeberg A; Mallbris L; Gislason GH; Skov L; Hansen PR J Invest Dermatol; 2016 Jan; 136(1):93-8. PubMed ID: 26763428 [TBL] [Abstract][Full Text] [Related]
33. Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observational study in Central and Eastern European countries. Raam L; Hartmane I; Valiukevičienė S; Karamova AE; Telegdy E; Botev I; Marina D; Rubant S; Albuquerque T; Constantin MM Front Immunol; 2024; 15():1410540. PubMed ID: 38846952 [TBL] [Abstract][Full Text] [Related]
34. Association of Behçet disease with psoriasis and psoriatic arthritis. Hahn HJ; Kwak SG; Kim DK; Kim JY Sci Rep; 2021 Jan; 11(1):2531. PubMed ID: 33510251 [TBL] [Abstract][Full Text] [Related]
35. Multiple sclerosis is associated with psoriasis. A case-control study. Fellner A; Dano M; Regev K; Mosek A; Karni A J Neurol Sci; 2014 Mar; 338(1-2):226-8. PubMed ID: 24439200 [TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Psychiatric Disorders in Patients with Multiple Sclerosis-A Single-Center Study in the Polish Population. Mado H; Błachut M; Szczegielniak A; Świerzy K; Zając M; Kubicka-Bączyk K; Gorczyca P; Adamczyk-Sowa M Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541102 [No Abstract] [Full Text] [Related]
37. Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry. Mease PJ; Blauvelt A; Sima AP; Beaty SW; Low R; Gomez B; Gurrola M; Lebwohl MG Dermatol Ther (Heidelb); 2024 Oct; 14(10):2805-2825. PubMed ID: 39283415 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. Reder AT; Centonze D; Naylor ML; Nagpal A; Rajbhandari R; Altincatal A; Kim M; Berdofe A; Radhakrishnan M; Jung E; Sandrock AW; Smirnakis K; Popescu C; de Moor C CNS Drugs; 2021 Mar; 35(3):317-330. PubMed ID: 33743151 [TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236 [TBL] [Abstract][Full Text] [Related]
40. Psoriasis and multiple sclerosis: is there a link? Kwok T; Jing Loo W; Guenther L J Cutan Med Surg; 2010; 14(4):151-5. PubMed ID: 20642982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]